Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VASSPR in Septic Shock
NCT06217562Phase 4Completed
- Sponsor
- Intermountain Health
- Start
- Feb 2024
- Primary completion
- Feb 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vasopressin in septic shock, sponsored by Intermountain Health. Started Feb 2024; status: completed.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06217562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06217562.